as informed in msnewsnow
Mylan to offer generic EpiPen
Mylan to offer generic EpiPen
A cheaper generic version of the emergency allergy treatment EpiPen will be made available within the next few weeks, manufacturer Mylan said Monday.A cheaper generic version of the emergency allergy treatment EpiPen will be made available within the next few weeks, manufacturer Mylan said Monday.In yet another example of the damage that maternal Zika infection can inflict on a fetus during the early months of pregnancy, a new report suggests that close to 6 percent of these babies may also experience hearing loss.
additionally unionleader
Mylan to launch generic EpiPen at half the price of original
Mylan to launch generic EpiPen at half the price of original
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington.(REUTERS/Jim Bourg/File Photo)Mylan to launch generic EpiPen at half the price of originalMylan NV said it would launch the first generic version of its allergy auto-injector EpiPen for $300, half the price of the branded product, the drugmaker's second step in less than a week to counter the backlash over the product's steep price.The company reduced the out-of-pocket costs of EpiPen for some patients on Thursday, but kept the list price at about $600, a move that U.S. lawmakers and Presidential candidate Hillary Clinton said was not enough.
in like manner heraldtribune
Mylan launching generic version of EpiPen
Mylan launching generic version of EpiPen
NEW YORK - Mylan says it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine.The company said Monday that its U.S. subsidiary will put out a generic version of the EpiPen that will have a list price of $300 for a two-pack — about half the current price.It will be available in both 0.15 mg and 0.30 mg strengths.
moreover from statnews
How the generic EpiPen can actually boost profits for Mylan
How the generic EpiPen can actually boost profits for Mylan
In the latest twist on the EpiPen saga, drug maker Mylan appears to have figured out a way to make more money on the product — while chopping the price in half.Mylan's new plan is to sell a generic version of its EpiPen directly to consumers, in what CEO Heather Bresch called an "extraordinary commercial response." The new product, expected in the coming weeks, will be identical to EpiPen except for the label, and will sell for $300 for a two-pack — about half the cost of the EpiPen.Here's what we know about the move:Why would Mylan do this?
No comments:
Post a Comment